ampelopsin has been researched along with Cerebral Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dinda, AK; Joshi, B; Reeta, KH; Sharma, U; Singh, D; Upadhyay, D; Wasan, H | 1 |
| Chen, C; Cheng, Q; Ding, H; Fang, J; Fang, X; Liu, H; Wang, Z; Zhang, J; Zhang, W | 1 |
2 other study(ies) available for ampelopsin and Cerebral Ischemia
| Article | Year |
|---|---|
Dihydromyricetin alleviates cerebral ischemia-reperfusion injury by attenuating apoptosis and astrogliosis in peri-infarct cortex.
Topics: Animals; Apoptosis; Brain Ischemia; Cerebral Cortex; Disease Models, Animal; Flavonols; Gliosis; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury | 2022 |
Dihydromyricetin Alleviates Ischemic Brain Injury by Antagonizing Pyroptosis in Rats.
Topics: Animals; Brain Injuries; Brain Ischemia; Humans; Ischemic Stroke; Pyroptosis; Rats; Rats, Sprague-Dawley | 2023 |